Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorGADGEEL, S. M.
dc.contributor.authorMOK, T. S. K.
dc.contributor.authorPETERS, S.
dc.contributor.authorALEXANDER, J. A. A.
dc.contributor.authorLEIGHL, N. B.
dc.contributor.authorSRIURANPONG, V.
dc.contributor.authorPEROL, M.
dc.contributor.authorCASTRO JR., G. De
dc.contributor.authorNADAL, E.
dc.contributor.authorMARINIS, F. De
dc.contributor.authorHAN, J-Y.
dc.contributor.authorYAN, M.
dc.contributor.authorRIEHL, T.
dc.contributor.authorSCHLEIFMAN, E.
dc.contributor.authorPAUL, S. M.
dc.contributor.authorMOCCI, S.
dc.contributor.authorSHAMES, D.
dc.contributor.authorMATHISEN, M. S.
dc.contributor.authorDZIADZIUSZKO, R.
dc.identifier.citationANNALS OF ONCOLOGY, v.30, suppl.5, p.918-918, 2019
dc.description.sponsorshipF. Hoffman-La Roche Ltd.
dc.publisherOXFORD UNIV PRESSeng
dc.relation.ispartofAnnals of Oncology
dc.titlePhase II/III blood first assay screening trial (BFAST) in patients (pts) with treatment-naive NSCLC: Initial results from the ALK plus cohorteng
dc.rights.holderCopyright OXFORD UNIV PRESSeng
dc.description.conferencedateSEP 27-OCT 01, 2019
dc.description.conferencelocalBarcelona, SPAIN
dc.description.conferencename44th Congress of the European-Society-for-Medical-Oncology (ESMO)
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng, S. M.:Univ Michigan, Dept Internal Med, Rogel Canc Ctr, Ann Arbor, MI 48109 USA, T. S. K.:Chinese Univ Hong Kong, State Key Lab Translat Oncol, Hong Kong, Peoples R China, S.:Univ Hosp Vaudois CHUV, Multidisciplinary Oncol Ctr, Lausanne, Switzerland, J. A. A.:Hlth Pharma Profess Res, Clin Oncol Toracia, New Mexico, Mexico, N. B.:Princess Margaret Canc Ctr, CCRU, Toronto, ON, Canada, V.:King Chulalongkorn Mem Hosp, Med Oncol Unit, Bangkok, Thailand, M.:Leon Berard Canc Ctr, Dept Med Oncol, Lyon, France, E.:Catalan Inst Oncol, Barcelona, Spain, F. De:European Inst Oncol, IRCCS, Milan, Italy, J-Y.:Natl Canc Ctr, Med Oncol, Goyang, South Korea, M.:F Hoffmann La Roche, Med Oncol, Mississauga, ON, Canada, T.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA, E.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA, S. M.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA, S.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA, D.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA, M. S.:Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA, R.:Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland
hcfmusp.description.issuesuppl 5
Appears in Collections:

Comunicações em Eventos - FM/MDR
Departamento de Radiologia - FM/MDR

Comunicações em Eventos - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Comunicações em Eventos - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.